Virus-Like Particles With Controllable Release Deliver Venom Peptide Drugs | Research

The takeaway

A ROMP-based chemical trigger enables controllable disassembly of virus-like nanoparticles under physiological conditions, solving a key challenge for in vivo delivery of therapeutic venom peptides.

Controllable release achieved
ROMP-triggered VLP disassembly works under physiological conditions — the first controllable release mechanism independent of pH or cell-specific factors for venom peptide delivery

What the researchers found

Ring-opening metathesis polymerization (ROMP) mechanism enables controllable P22 VLP disassembly under physiological conditions (neutral pH, moderate temperature). Norbornene-conjugated VLPs disassemble upon AquaMet catalyst treatment, releasing GFP reporter cargo.

Why it matters

Therapeutic venom peptides (like the pain drug ziconotide) are potent but fragile. A nanoparticle delivery system with on-demand release could protect peptide drugs during circulation and release them specifically at disease sites.

The numbers in context

Disassembly confirmed by electrophoresis, TEM, and DLS at neutral pH and moderate temperature

How the study worked

Chemical biology study. Norbornene conjugated to P22 VLP surface lysines. ROMP induced by water-soluble AquaMet ruthenium catalyst. Disassembly confirmed by native agarose electrophoresis, TEM, and dynamic light scattering. Adaptable to other VLP prototypes.

Who was studied

P22 bacteriophage-derived virus-like particles

What this study cannot tell us

Proof-of-concept with GFP reporter, not actual venom peptide cargo. AquaMet catalyst administration in vivo may have safety concerns. Release kinetics and spatial control not optimized. In vivo delivery not tested.

How to read the evidence

Low evidence grade: proof-of-concept with reporter protein cargo. No therapeutic peptide loading or in vivo testing.

When this study was published

Published 2021. VLP-based drug delivery continues advancing with improved triggered release mechanisms.

The bigger picture

Controllable drug release from nanoparticles is a holy grail of drug delivery. Chemical triggers that work under body conditions — independent of cell type or pH — provide a universal release mechanism applicable to many therapeutic peptides.

Questions still open

Can AquaMet catalyst be safely administered in vivo to trigger VLP release?
Would venom peptides maintain their bioactivity after VLP encapsulation and release?
Can the ROMP trigger be localized to specific tissues for targeted release?

Common questions

What are virus-like particles?

VLPs are empty protein shells that look like viruses but contain no genetic material and cannot cause infection. They can be loaded with drugs and used as nano-scale delivery vehicles to protect sensitive peptide drugs during circulation in the body.

Why is controllable release important?

Without controllable release, drug-loaded nanoparticles may release their cargo too early (in the blood) or too late (after the disease window). A chemical trigger that releases drugs on demand ensures the right dose reaches the right place at the right time.

Read the original research

Induced Disassembly of a Virus-like Particle under Physiological Conditions for Venom Peptide Delivery.

Bioconjugate chemistry, 32(1), 111-120

View on PubMed ↗Publisher’s paper ↗

Citation

Kelly, M Patrick; Napolitano, Tanya; Anand, Prachi; Ho, Justin S K; Jabeen, Shakeela; Kuppan, Jessica; Manir, Sujoy; Holford, Mandë. (2021). Induced Disassembly of a Virus-like Particle under Physiological Conditions for Venom Peptide Delivery.. Bioconjugate chemistry, 32(1), 111-120. https://doi.org/10.1021/acs.bioconjchem.0c00494